uniQure N.V. and Medison Pharma Ltd., Israel’s leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera ®, uniQure’s gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority.